Anakinra + Adalimumab Aaty Interaction
Majorinteraction on record
Description
Increased risk of serious infection with no added benefit. Concomitant use not recommended in patients with RA.
Mechanism
TNF blocker combined with biologic DMARD increases infection risk
Source: NLP:adalimumab-aaty